Infliximab in recalcitrant granuloma annulare

Int J Dermatol. 2016 Feb;55(2):220-2. doi: 10.1111/ijd.12458. Epub 2014 Jun 25.

Authors

Maud Amy de la Breteque¹, Anne Saussine¹, Michel Rybojad¹, Nora Kramkimel¹, Marie-Dominique Vignon Pennamen², Martine Bagot¹, Fabien Guibal¹

Affiliations

¹ Department of Dermatology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Diderot Saint Louis Hospital, University of Paris Diderot, Paris, France.
² Department of Pathology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Diderot Saint Louis Hospital, University of Paris Diderot, Paris, France.

PMID: 24962456
DOI: 10.1111/ijd.12458

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Dermatologic Agents / therapeutic use*
Female
Granuloma Annulare / drug therapy*
Granuloma Annulare / pathology
Humans
Infliximab / therapeutic use*
Retreatment

Substances

Dermatologic Agents
Infliximab